December 5, 2023 December 5, 2023€ 1.4 million for the acceleration of VivArt-X research€ 1.4 million for the acceleration of VivArt-X research The Eindhoven startup VivArt-X collaborate with Smart BioMaterials Consortium (SBMC) and […]
November 16, 2023 November 16, 2023VivArt-X closed pre-seed roundVivArt-X closed pre-seed round VivArt-X Closes Pre-Seed Investment Round! We are thrilled to announce that VivArt-X has successfully closed our […]
September 28, 2023 September 28, 2023Top 3 of the most promising startups – Brabant40 Award 2023Top 3 of the most promising startups – Brabant40 Award 2023 VivArt-X was selected as one of the top 3 […]
September 27, 2023 September 27, 2023VivArt-X receives the SIR subsidy 2023VivArt-X receives the SIR subsidy 2023 VivArt-X has been awarded the SIR subsidy for innovative startups in Brabant. This project […]
September 21, 2023 September 21, 2023European Innovation Award 2023European Innovation Award 2023 🚀 ESDP Innovation Challenge: Better Ideas, for a Better World 🌟 VivArt-X was shortlisted as a […]
August 31, 2023 August 31, 2023Gerard & Anton Awards 2023Gerard & Anton Awards 2023 🏆 It’s an honor for VivArt-X to be awarded Gerard and Anton Phillips’ Award as one of […]
July 25, 2023 July 25, 2023BNR radio interviewBNR radio interview Thanks BNR Nieuwsradio for having our CEO Dan Jing Wu and CEO of STENTiT Bart Sanders and […]
July 13, 2023 July 13, 2023VivArt-X receives the MIT Feasibility study 2023VivArt-X receives the MIT Feasibility study 2023 Funding news! VivArt-X has been awarded the MIT feasibility study grant (“MIT Haalbaarheidsprojecten”) […]
June 15, 2023 June 15, 2023VivArt-X featured in a Marie Claire article!VivArt-X featured in a Marie Claire article! SCIENTIST & ENTREPRENEUR Dan Jing Wu in Marie Claire: “I have always found […]